title: Liver involvement in patients with brucellosis: results of the Marmara study.
abstract: Brucellosis is a zoonotic disease that primarily affects the reticuloendothelial system. But, the extent of liver damage in due course of the disease is unclear. This study included 325 brucellosis patients with significant hepatobiliary involvement identified with microbiological analyses from 30 centers between 2000 and 2013. The patients with ≥5 times of the upper limit of normal for aminotransferases, total bilirubin level ≥2 mg/dl or local liver lesions were enrolled. Clinical hepatitis was detected in 284 patients (87.3 %) and cholestasis was detected in 215 (66.1 %) patients. Fatigue (91 %), fever (86 %), sweating (83 %), arthralgia (79 %), and lack of appetite (79 %) were the major symptoms. Laboratory tests showed anemia in 169 (52 %), thrombocytopenia in 117 (36 %), leukopenia in 81 (25 %), pancytopenia in 42 (13 %), and leukocytosis in 20 (6 %) patients. The most commonly used antibiotic combinations were doxycycline plus an aminoglycoside (n = 73), doxycycline plus rifampicin (n = 71), doxycycline plus rifampicin and an aminoglycoside (n = 27). The duration of ALT normalization differed significantly in three treatment groups (p < 0.001). The use of doxycycline and an aminoglycoside in clinical hepatitis showed better results compared to doxycycline and rifampicin or rifampicin, aminoglycoside, doxycycline regimens (p < 0.05). However, the length of hospital stay did not differ significantly between these three combinations (p > 0.05). During the follow-up, treatment failure occurred in four patients (1 %) and relapse was seen in three patients (0.9 %). Mortality was not observed. Hepatobiliary involvement in brucellosis has a benign course with suitable antibiotics and the use of doxycycline and an aminoglycoside regimen seems a better strategy in select patients.
authors.affiliation: Department of Infectious Diseases and Clinical Microbiology, Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey.
authors.forename: D
authors.initials: D
authors.lastname: Ozturk-Engin
authors.forename: H
authors.initials: H
authors.lastname: Erdem
authors.forename: S
authors.initials: S
authors.lastname: Gencer
authors.forename: S
authors.initials: S
authors.lastname: Kaya
authors.forename: A I
authors.initials: AI
authors.lastname: Baran
authors.forename: A
authors.initials: A
authors.lastname: Batirel
authors.forename: R
authors.initials: R
authors.lastname: Tekin
authors.forename: M K
authors.initials: MK
authors.lastname: Celen
authors.forename: A
authors.initials: A
authors.lastname: Denk
authors.forename: S
authors.initials: S
authors.lastname: Guler
authors.forename: M
authors.initials: M
authors.lastname: Ulug
authors.forename: H
authors.initials: H
authors.lastname: Turan
authors.forename: A U
authors.initials: AU
authors.lastname: Pekok
authors.forename: G
authors.initials: G
authors.lastname: Mermut
authors.forename: S
authors.initials: S
authors.lastname: Kaya
authors.forename: M
authors.initials: M
authors.lastname: Tasbakan
authors.forename: N
authors.initials: N
authors.lastname: Tulek
authors.forename: Y
authors.initials: Y
authors.lastname: Cag
authors.forename: A
authors.initials: A
authors.lastname: Inan
authors.forename: A
authors.initials: A
authors.lastname: Yalci
authors.forename: C
authors.initials: C
authors.lastname: Ataman-Hatipoglu
authors.forename: I
authors.initials: I
authors.lastname: Gonen
authors.forename: A
authors.initials: A
authors.lastname: Dogan-Celik
authors.forename: F
authors.initials: F
authors.lastname: Bozkurt
authors.forename: S
authors.initials: S
authors.lastname: Gulsun
authors.forename: M
authors.initials: M
authors.lastname: Sunnetcioglu
authors.forename: T
authors.initials: T
authors.lastname: Guven
authors.forename: F
authors.initials: F
authors.lastname: Duygu
authors.forename: E
authors.initials: E
authors.lastname: Parlak
authors.forename: H
authors.initials: H
authors.lastname: Sozen
authors.forename: S
authors.initials: S
authors.lastname: Tosun
authors.forename: T
authors.initials: T
authors.lastname: Demirdal
authors.forename: E
authors.initials: E
authors.lastname: Guclu
authors.forename: O
authors.initials: O
authors.lastname: Karabay
authors.forename: N
authors.initials: N
authors.lastname: Uzun
authors.forename: O
authors.initials: O
authors.lastname: Gunal
authors.forename: H
authors.initials: H
authors.lastname: Diktas
authors.forename: A
authors.initials: A
authors.lastname: Haykir-Solay
authors.forename: A
authors.initials: A
authors.lastname: Erbay
authors.forename: C
authors.initials: C
authors.lastname: Kader
authors.forename: O
authors.initials: O
authors.lastname: Aydin
authors.forename: A
authors.initials: A
authors.lastname: Erdem
authors.forename: N
authors.initials: N
authors.lastname: Elaldi
authors.forename: A
authors.initials: A
authors.lastname: Kadanali
authors.forename: Z
authors.initials: Z
authors.lastname: Yulugkural
authors.forename: L
authors.initials: L
authors.lastname: Gorenek
authors.forename: M
authors.initials: M
authors.lastname: Altındis
authors.forename: S
authors.initials: S
authors.lastname: Bolukcu
authors.forename: C
authors.initials: C
authors.lastname: Agalar
authors.forename: N
authors.initials: N
authors.lastname: Ormeci
mesh_terms: D000328:Adult; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001663:Bilirubin; D002006:Brucellosis / Q000150:complications* / Q000188:drug therapy / Q000473:pathology*; D005260:Female; D006505:Hepatitis / Q000209:etiology* / Q000473:pathology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D000637:Transaminases; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D000900:Anti-Bacterial Agents; D000637:Transaminases; D001663:Bilirubin